Cefpodoxime Proxetil
Who holds supplier records for Cefpodoxime Proxetil? 9 organisations hold a current record for Cefpodoxime Proxetil: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 4 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (5), China (2), Germany (1) and South Korea (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Cefpodoxime Proxetil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/cefpodoxime-proxetil
Reading the evidence
- 9 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 4 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
Current records (9)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Cefpodoxime Proxetil. Country is the organisation's recorded country, not necessarily the manufacturing site.
- APITORIA PHARMA PRIVATE LTDIndia Company GMP cert on recordActive DMF 18941, 39541 · latest filing Mar 2024
- PURE AND CURE HEALTHCARE PRIVATE LTDIndiaCEPActive DMF 23572 · latest filing Feb 2010
- Qilu Antibiotics Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 34502 · latest filing Feb 2020
- Ceph Lifesciences Private LimitedIndiaActive DMF 27071 · latest filing Jun 2014
- COVALENT LABORATORIES PRIVATE LTDIndiaActive DMF 29791 · latest filing Sept 2015
- Orchid Pharma LimitedIndia Company GMP cert on recordActive DMF 18505 · latest filing Jul 2005
- Sandoz GmbHGermanyCEP Company GMP cert on recordActive DMF 20076 · latest filing Dec 2006
- Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd.ChinaActive DMF 44832 · latest filing Sept 2026
- Jeil Pharmaceutical Co.,ltd.South KoreaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (4)
Certificates of Suitability on the EDQM register for Cefpodoxime Proxetil, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 11 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| PURE AND CURE HEALTHCARE PRIVATE LIMITED Sahibzada Ajit Singh Nagar | IN | CEP 2025-561 - Rev 00 Cefpodoxime proxetil, Process-II | May 2026 | — |
| QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. Jinan | CN | CEP 2020-399 - Rev 02 Cefpodoxime proxetil, Process 3 | Nov 2025 | Inspected Jun 2026 Austria |
| JEIL PHARMACEUTICAL CO., LTD. Yongin-si | KR | R1-CEP 2015-146 - Rev 00 Cefpodoxime proxetil | Apr 2022 | — |
| SANDOZ GMBH Kundl | AT | R1-CEP 2010-283 - Rev 01 Cefpodoxime proxetil | Dec 2017 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Cefpodoxime Proxetil are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- India · Inactive DMF 16542 · filed Apr 2003
- India · Inactive DMF 15192 · filed Dec 2000
Overview
Cefpodoxime Proxetil is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1201016).
Chemical identity
- IUPAC name
- 1-propan-2-yloxycarbonyloxyethyl (6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-methoxyiminoacetyl]amino]-3-(methoxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
- Canonical SMILES
- CC(C)OC(=O)OC(C)OC(=O)C1=C(CS[C@H]2N1C(=O)[C@H]2NC(=O)/C(=N\OC)/C3=CSC(=N3)N)COC
- InChIKey
- LTINZAODLRIQIX-FBXRGJNPSA-N
- Synonyms
- Banan, Cefodox, Cefpodoxime proxetil, CS-807, NSC-759161, Otreon, Podomexef, Simplicef, U-76252, Vantin, Orelox, CHEBI:3505
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Cephalosporin Antibacterial
- Chemical structure
- Cephalosporins
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Cefpodoxime Proxetil?
9 organisations hold an active US FDA Type II Drug Master File or a CEP for Cefpodoxime Proxetil: APITORIA PHARMA PRIVATE LTD (India), PURE AND CURE HEALTHCARE PRIVATE LTD (India), Qilu Antibiotics Pharmaceutical Co., Ltd. (China), Ceph Lifesciences Private Limited (India), COVALENT LABORATORIES PRIVATE LTD (India), Orchid Pharma Limited (India), Sandoz GmbH (Germany) and Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd. (China), and 1 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Cefpodoxime Proxetil Drug Master Files are active?
APITORIA PHARMA PRIVATE LTD (DMF 18941, 39541), PURE AND CURE HEALTHCARE PRIVATE LTD (DMF 23572), Qilu Antibiotics Pharmaceutical Co., Ltd. (DMF 34502), Ceph Lifesciences Private Limited (DMF 27071), COVALENT LABORATORIES PRIVATE LTD (DMF 29791), Orchid Pharma Limited (DMF 18505), Sandoz GmbH (DMF 20076) and Zhejiang Apeloa Tospo Pharmaceutical Co., Ltd. (DMF 44832). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Cefpodoxime Proxetil records mean?
2 organisations have only inactive Type II DMFs for Cefpodoxime Proxetil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Cefpodoxime Proxetil have a European Certificate of Suitability?
Yes. 4 organisations hold a valid CEP for Cefpodoxime Proxetil on the EDQM register, including PURE AND CURE HEALTHCARE PRIVATE LIMITED Sahibzada Ajit Singh Nagar (IN), QILU ANTIBIOTICS PHARMACEUTICAL CO. LTD. Jinan (CN), JEIL PHARMACEUTICAL CO., LTD. Yongin-si (KR) and SANDOZ GMBH Kundl (AT). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
How do I qualify a Cefpodoxime Proxetil supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Cefpodoxime Proxetil?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.